+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Savara Pharmaceuticals - logo

Savara Pharmaceuticals is a company that develops products for rare and life threatening respiratory diseases. Savara is a US based company with an affiliate company in Copenhagen, Denmark established in 2008. They have 3 main products: Molgradex, AeroVanc & Aironite. Molgradex is an inhalation medication used for the treatment of PAP. Aerovanc is another drug used to combat MRSA (Methicillin-resistant Staphylococcus aureus). Aironite is inhaled through nebulizer to treat heart failure patients with preserved ejection fraction (HFpEF).

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
From
From
Inhaled Antibiotics Market Report 2025 - Product Thumbnail Image

Inhaled Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Rare Kidney Diseases Market Report 2025 - Product Thumbnail Image

Rare Kidney Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator